Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

Concerns mount over rival vaccines

Concerns mount over rival vaccines

CARL O’DONNELL WEALTHY governments are looking to COVID-19 shots from Pfizer Inc and Moderna Inc to keep their vaccination programs on track, as safety concerns and production problems sideline vaccines from AstraZeneca Plc and Johnson & Johnson, public health experts and industry analysts say. Countries in Europe and Asia, as well as South Africa, are limiting or halting use of AstraZeneca's shot over safety concerns. Rollout of J&J's one-shot vaccine was paused in the United States and Europe this week over a handful of cases of very rare but dangerous blood clots in the brain, much like AstraZeneca's safety issue.…
Read More
EXPLAINER – When and how will COVID-19 vaccines become available?

EXPLAINER – When and how will COVID-19 vaccines become available?

JULIE STEENHUYZEN and CARL O’DONNELL PFIZER Inc with partner BioNTech SE and Moderna Inc have released trial data showing their COVID-19 vaccines to be about 95% effective at preventing the illness, while AstraZeneca Plc this week said its vaccine could be up to 90% effective. If regulators approve any of the vaccines in coming weeks, the companies have said distribution could begin almost immediately with governments around the world to decide who gets them and in what order. The following is an outline of the process: WHEN WILL COMPANIES ROLL OUT A VACCINE? Pfizer, Moderna and AstraZeneca have already started…
Read More
Wave of new COVID-19 cases crashes across U.S. and Europe as winter looms

Wave of new COVID-19 cases crashes across U.S. and Europe as winter looms

JAMES MACKENZIE and LISA SHUMAKER THE United States, Russia, France and many other countries are setting records for coronavirus infections as a tidal wave of cases washes over parts of the Northern Hemisphere, forcing some countries to impose new curbs. The gloom weighed on global financial markets on Monday as surging infections clouded the economic outlook. U.S. stocks had their worst day in more than seven weeks over the double whammy of record coronavirus cases and political deadlock in negotiations to provide more economic aid. Word that a vaccine being developed by the University of Oxford and AstraZeneca Plc produced…
Read More